Santhera Pharmaceuticals Holding Management
Management criteria checks 3/4
Santhera Pharmaceuticals Holding's CEO is Dario Eklund, appointed in Dec 2019, has a tenure of 4.5 years. total yearly compensation is CHF1.72M, comprised of 30.1% salary and 69.9% bonuses, including company stock and options. directly owns 0.049% of the company’s shares, worth CHF43.65K. The average tenure of the management team and the board of directors is 2.3 years and 4.1 years respectively.
Key information
Dario Eklund
Chief executive officer
CHF1.7m
Total compensation
CEO salary percentage | 30.1% |
CEO tenure | 4.5yrs |
CEO ownership | 0.05% |
Management average tenure | 2.3yrs |
Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | CHF2m | CHF516k | CHF55m |
Sep 30 2023 | n/a | n/a | -CHF5m |
Jun 30 2023 | n/a | n/a | -CHF65m |
Mar 31 2023 | n/a | n/a | -CHF68m |
Dec 31 2022 | CHF2m | CHF505k | -CHF71m |
Sep 30 2022 | n/a | n/a | -CHF68m |
Jun 30 2022 | n/a | n/a | -CHF65m |
Mar 31 2022 | n/a | n/a | -CHF60m |
Dec 31 2021 | CHF1m | CHF500k | -CHF56m |
Sep 30 2021 | n/a | n/a | -CHF56m |
Jun 30 2021 | n/a | n/a | -CHF56m |
Mar 31 2021 | n/a | n/a | -CHF62m |
Dec 31 2020 | CHF681k | CHF500k | -CHF68m |
Sep 30 2020 | n/a | n/a | -CHF46m |
Jun 30 2020 | n/a | n/a | -CHF24m |
Mar 31 2020 | n/a | n/a | -CHF21m |
Dec 31 2019 | CHF2m | CHF42k | -CHF19m |
Compensation vs Market: Dario's total compensation ($USD1.93M) is above average for companies of similar size in the UK market ($USD357.78K).
Compensation vs Earnings: Dario's compensation has been consistent with company performance over the past year.
CEO
Dario Eklund (56 yo)
4.5yrs
Tenure
CHF1,715,974
Compensation
Mr. Dario Eklund has been Chief Executive Officer at Santhera Pharmaceuticals Holding AG since December 1, 2019. He served as Head of Global Business Operations at Vifor Pharma Ltd. since 2014.He served a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Chairman | 7.2yrs | CHF200.00k | 0.34% CHF 301.5k | |
Chief Executive Officer | 4.5yrs | CHF1.72m | 0.049% CHF 43.6k | |
Chief Financial Officer | 4.2yrs | no data | no data | |
General Counsel & Secretary | 18.4yrs | no data | no data | |
Head Business Development | no data | no data | 0.011% CHF 9.7k | |
Chief Medical Officer | no data | no data | 0.029% CHF 25.7k | |
Chief Technology Officer | less than a year | no data | no data | |
Head of Investor Relations & Communications | 2.1yrs | no data | no data | |
Head of Global Marketing & Partner Management | no data | no data | no data | |
Head of People & Culture | 2.3yrs | no data | no data | |
Head of Clinical Development Operations | 2.1yrs | no data | no data | |
Chief of Staff | no data | no data | no data |
2.3yrs
Average Tenure
62yo
Average Age
Experienced Management: SANNZ's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Chairman | 7.2yrs | CHF200.00k | 0.34% CHF 301.5k | |
Director | less than a year | CHF143.75k | no data | |
Director | less than a year | CHF168.75k | 0.034% CHF 30.0k | |
Non Executive Independent Director | 7.2yrs | CHF145.00k | 0.15% CHF 130.9k |
4.1yrs
Average Tenure
59yo
Average Age
Experienced Board: SANNZ's board of directors are considered experienced (4.1 years average tenure).